Health & Fitness
Health and Fitness
Health and Fitness
Thu, December 4, 2008
Wed, December 3, 2008
Tue, December 2, 2008 Biodel to Report Fourth Quarter and Fiscal Year 2008 Financial Results on December 10, 2008
DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter and fiscal year 2008 financial results on December 10, 2008. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.
December 10, 2008 schedule:
| 7:00 am EST: | Q4 and fiscal year 2008 results will be | ||||||||
| distributed by Business Wire | |||||||||
| 7:50 am EST: | Conference call participants should dial: | ||||||||
| +1 877-852-6575 (United States) or | |||||||||
| +1 719-325-4815 (International) | |||||||||
| 8:00 am EST: | Conference call begins |
Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at [ http://www.biodel.com ]. The audio webcast will be archived and available for replay through the website.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.Biodel.com ].
BIOD-G
